Citi Raises Lexicon Pharmaceuticals Target — Boosting Biotech Valuations
Citi lifts Lexicon’s target to $95 from $80, signaling a 18% upside that could lift the broader biotech index.
All Cowlpane coverage tagged price target, sourced from global financial publications and updated continuously.
Citi lifts Lexicon’s target to $95 from $80, signaling a 18% upside that could lift the broader biotech index.
Wells Fargo lifts Marvell’s target to $195, citing AWS Trainium and custom silicon momentum that could reshape data‑center supply chains.
Morgan Stanley raised Dell’s price target to $55, but warns earnings volatility could cap gains for hardware‑heavy investors.
NEAR’s $142.37 price target floods social media, but on‑chain data shows only modest activity, raising doubts about the rally’s legitimacy.
Wells Fargo lifts Amazon’s target to $312, highlighting AWS’s growing margin power and a bullish case for cloud equity rotation.
The company aims to push its share above $18 thirty days before Sep 9, a move that could trigger forced redemption and fresh capital.
Deutsche Bank raised Charles Schwab’s price target to $78, signaling stronger earnings and prompting investors to tilt toward broker‑dealers.
SOFI must trade above $27 by year‑end for a first‑time trader to recoup his loss, a level that could trigger fresh buying pressure.